Sproxil, Inc. Teams with IBM to Help Consumers, Industry, in the Fight Against Drug Counterfeiting
May 1, 2012
Sproxil, co-founded by Ph.D. Innovation Program alum Ashifi Gogo, is using IBM technology to help the pharmaceutical industry reduce drug counterfeiting and allow consumers to verify the authenticity of prescriptions in seconds with their mobile phones.
Through its collaboration with IBM, Sproxil is extending manufacturers’ ability to view and analyze real time consumer data to detect and prevent drug counterfeiting in developing countries, where 25 to 50 percent of medicines are believed to be counterfeit, costing the industry $75 billion a year. With the collaboration, Sproxil also uses IBM’s cloud service to provide clients with secure, reliable data access virtually anywhere.